Rise Advisors’s Insmed INSM Stock Holding History

Rise Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-316	Closed	-$45.5K	–	737
2025 Q3	$45.5K	Hold	316	–	–	0.02%	270
2025 Q2	$31.8K	Hold	316	–	–	0.01%	326
2025 Q1	$24.1K	Buy	+316	New	+$24.2K	0.01%	411

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Rise Advisors's INSM Position: Q4 2025 in Review

Rise Advisors sold out of Insmed (INSM) in Q4 2025, closing a stake of 316 shares — an estimated $45.5K sold.

Rise Advisors first reported a position in INSM in Q1 2025 and held it in 3 quarters. The position peaked at $45.5K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

Rise Advisors reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 316 Insmed shares in Q4 2025, an estimated $45.5K.
Rise Advisors first reported a position in Insmed in Q1 2025 and held it in 3 quarters.
Rise Advisors's Insmed position peaked at $45.5K in Q3 2025.
678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.